SEC Filings TLDR

On October 25, 2025, Scot Michael Elder, Chief Legal & Compliance Officer and Corporate Secretary of Treace Medical Concepts, Inc., disposed of 984 shares of common stock. The transaction was coded as 'F' and resulted in a post-transaction ownership of 548,281 shares, which includes 426,170 restricted stock units. The ...

On October 24, 2025, Todd Schuster, a director of TPG RE Finance Trust, Inc. (TRTX), acquired 137 additional shares of common stock at a price of $8.62 per share. This transaction increased his total holdings to 50,512 shares. The shares were acquired through deferred stock units (DSUs) issued in lieu of dividends. The...

On October 24, 2025, Wendy Silverstein, a director of TPG RE Finance Trust, Inc. (TRTX), acquired 998 shares of common stock at a price of $8.62 per share. This transaction increased her total holdings to 82,376 shares. The shares were acquired through deferred stock units (DSUs) issued in lieu of dividends. The DSUs w...

On October 24, 2025, Michael Gillmore, a director of TPG RE Finance Trust, Inc. (TRTX), acquired 998 shares of common stock at a price of $8.62 per share. Following this transaction, Gillmore directly owned 82,376 shares of common stock. Additionally, Gillmore indirectly owns 500 shares of common stock through a person...

On October 24, 2025, Michael Bradley Smith, a director of TPG RE Finance Trust, Inc. (TRTX), acquired 998 shares of common stock at a price of $8.62 per share. This transaction was part of the issuance of deferred stock units (DSUs) in lieu of cash dividends. The DSUs were calculated based on the number of DSUs owned b...

On October 24, 2025, Gianluca Pettiti, Executive Vice President of Thermo Fisher Scientific Inc., sold 400 shares of the company's common stock at a price of $574.15 per share. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by Pettiti on February 10, 2025. Following the sale, Pettiti owns ...

Marc N. Casper, Chairman & CEO of Thermo Fisher Scientific Inc., engaged in multiple transactions involving the company's common stock and stock options between October 24 and October 27, 2025. These transactions were executed under a Rule 10b5-1 trading plan adopted on April 28, 2025. Casper acquired 24,354 shares of ...

Robert W. Stallings, a director of Texas Capital Bancshares Inc., has acquired additional shares in the company. On October 24, 2025, he acquired 10,000 depositary shares for Series B Preferred Stock at $20.61 per share, increasing his holdings to 265,913 shares. On October 27, 2025, he acquired an additional 5,000 dep...

On October 23, 2025, Adam Gishen, a director of SunPower Inc., sold 20,000 shares of common stock at a price of $2.04 per share. Following these transactions, Gishen's total holdings in the company decreased to 99,999 shares. The transactions were reported in a Form 4 filing with the SEC. Gishen's ownership nature is d...

On October 24, 2025, John Schutte, a director of Stock Yards Bancorp, Inc., acquired 94 shares of common stock at a price of $67.91 per share. This transaction increased his total holdings to 8,451 shares. The shares were acquired through the Trust Director Deferred Comp Plan. Schutte also holds 82,940 shares of common...

On October 24, 2025, Edwin S. Saunier, a director of Stock Yards Bancorp, Inc., acquired 47 shares of common stock at a price of $67.91 per share. This transaction increased his total holdings to 4,743 shares. The shares were acquired through a Trust - Director Deferred Comp Plan. Additionally, Saunier holds 6,156 shar...

Stephen M. Priebe, a director of Stock Yards Bancorp, Inc., acquired 95 shares of common stock on October 24, 2025, at a price of $67.91 per share. This transaction increased his total holdings to 32,580 shares, including shares acquired through automatic dividend reinvestment. Additionally, Priebe executed a Limited P...

David L. Hardy, a director of Stock Yards Bancorp, Inc., acquired 83 shares of common stock on October 24, 2025, at a price of $67.91 per share. Additionally, on October 21, 2025, Hardy acquired 1,000 stock appreciation rights (SARs) with an exercise price of $67.85, expiring on October 21, 2035. The SARs are linked to...

Paul J. Bickel III, a director of Stock Yards Bancorp, Inc., reported a transaction involving the acquisition of 101 shares of common stock on October 24, 2025, at a price of $67.91 per share. This transaction was part of the Trust Directors' Deferred Comp Plan. Following this transaction, Bickel owns a total of 15,078...

On October 24, 2025, Matthew Baer, the Chief Executive Officer of Stitch Fix, Inc., acquired 595,238 shares of Class A Common Stock. This transaction was reported under Form 4, indicating a change in beneficial ownership. The shares were acquired at a price of $0 per share, and following this transaction, Baer owns a t...

RA Capital Management, L.P., along with its affiliates RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund III, L.P., and a separately managed account, have reported the sale of shares in Sionna Therapeutics, Inc. The transactions occurred on October 24 and October 28, 2025, with shares so...

On October 27, 2025, Randall Moreadith, the Chief Scientific Officer of Serina Therapeutics, Inc., engaged in several transactions involving the company's common stock. Moreadith acquired 949 shares at $0.06 per share and subsequently sold the same number of shares at a weighted average price of $5.1857. Additionally, ...

Stephanie Tilenius, a director of Seagate Technology Holdings plc, was granted 1,580 restricted share units (RSUs) on October 25, 2025, under the company's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share of the company. The shares will be released to Tilenius on the earl...

On October 25, 2025, Seagate Technology Holdings plc granted 1,580 restricted share units (RSUs) to Thomas A. Szlosek, a director of the company, under the 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share of the issuer. The shares will be released to Szlosek on the earlie...

On October 25, 2025, Dylan G. Haggart, a director of Seagate Technology Holdings plc, was awarded 1,580 restricted share units (RSUs) under the company's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share of the company. The shares will be released to Haggart on the earlier...

Jay L. Geldmacher, a director of Seagate Technology Holdings plc, was awarded 1,580 restricted share units (RSUs) on October 25, 2025, under the company's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the company. The shares will be released to Geldmacher on the ear...

On October 25, 2025, Yolanda Lee Conyers, a director of Seagate Technology Holdings plc, was awarded 1,580 restricted share units (RSUs) under the company's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share of the issuer. The shares will be released to Conyers on the earli...

Richard L. Clemmer, a director of Seagate Technology Holdings plc, was granted 1,580 restricted share units (RSUs) on October 25, 2025, under the company's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the company. The shares will be released to Clemmer on the earli...

Michael R. Cannon, a director of Seagate Technology Holdings plc, was granted 1,868 restricted share units (RSUs) on October 25, 2025, under the company's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the company. The shares will be released to Mr. Cannon on the ear...

On October 25, 2025, Prat Bhatt, a director of Seagate Technology Holdings plc, was granted 1,580 restricted share units (RSUs) under the company's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share of the company. The shares will be released to Bhatt on the earlier of one ...